
Antibiotic use is increasing worldwide. This review examined the association between the use of antibiotics and the onset and development of type 1 and type 2 diabetes, inflammatory bowel disease, including ulcerative colitis and Crohn’s disease, as well as coeliac disease and eosinophilic oesophagitis. This review discusses the key findings of epidemiological studies, provide mechanistic insights into the pathways by which the gut microbiota might contribute to these diseases, and assess clinical trials investigating the effects of antibiotics. Such studies indicate that antibiotic exposures, varying in type, timing and dosage, could explain differences in disease risk. In addition, identifying the antibiotic-perturbed gut microbiota as a factor contributing to the pathophysiology of these inflammatory disorders might stimulate new approaches to prevention, diagnosis and treatment.
Like
Save
Share